Skip to main content
← Companies
LQDA

Liquidia Corp

Data as of Sep 17, 2026
LQDA
CIK 1819576Pharmaceutical Preparations

Lobbying

$420,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Health Issues$300K5 filings
  • Health Issues +1$120K2 filings

Latest filings, Apr 2025 onward

FiledRegistrant and subjectAmount
Jul 20, 2026
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues · Budget/Appropriations Health care and Judiciary issues related to FDA approval. CJS Appropriations.
$60,000
Apr 18, 2026
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues · Budget/Appropriations Health care and Judiciary issues related to FDA approval. CJS Appropriations.
$60,000
Jan 20, 2026
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues Health care and Judiciary issues related to FDA approval.
$60,000
Oct 20, 2025
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues Health care and Judiciary issues related to FDA approval.
$60,000
Jul 16, 2025
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues Health care and Judiciary issues related to FDA approval.
$60,000
Apr 17, 2025
THORN RUN PARTNERS for LIQUIDIA TECHNOLOGIES INC.
Health Issues Health care and Judiciary issues related to FDA approval.
$60,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Liquidia Corp through its SEC registration (CIK 1819576) and tickers LQDA.

As of: lobbying filings through Jul 20, 2026; contract actions through Dec 12, 2025. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.